+44 (0) 1223 755950
+1 832 327 7413
Click on the image to see the image legend
Target | CXCL17 |
Origin | Human |
Expression | Recombinant |
Tested Applications | SDS-PAGE |
Host | E. coli |
Conjugation | Unconjugated |
Form | Lyophilized |
Purity | > 97% (SDS-PAGE and RP-HPLC) |
Reconstitution | It is recommended to reconstitute the lyophilized CXCL17 in sterile 18M-cm H2O not less than 100 µg/ml, which can then be further diluted to other aqueous solutions. |
Storage | CXCL17 should be stored desiccated below -18 °C. Upon reconstitution CXCL17 should be stored at 4 °C between 2-7 days and for future use below -18 °C. Avoid repeated freeze/thaw cycles. |
UniProt Primary AC | Q6UXB2 (UniProt, ExPASy) |
UniProt Secondary AC | A8KAC0 |
UniProt Entry Name | CXL17_HUMAN |
KEGG | hsa:284340 |
String | 9606.ENSP00000472467 |
Sequence | SSLNPGVARG HRDRGQASRR WLQEGGQECE CKDWFLRAPR RKFMTVSGLP KKQCPCDHFK GNVKKTRHQR HHRKPNKHSR ACQQFLKQCQ LRSFALPL. |
Biological Activity | The ED5 as determined by its ability to induce VEGF expression using murine endothelial cells is less than 5.µg/ml, corresponding to a specific activity of > 2IU/mg. |
Availability | Shipped within 5-10 working days. |
Note | THIS PRODUCT IS FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC, THERAPEUTIC OR COSMETIC PROCEDURES. NOT FOR HUMAN OR ANIMAL CONSUMPTION. |